首页> 外文期刊>Journal of Analytical Methods in Chemistry >Electrochemical Analysis of Antichemotherapeutic Drug Zanosar in Pharmaceutical and Biological Samples by Differential Pulse Polarography
【24h】

Electrochemical Analysis of Antichemotherapeutic Drug Zanosar in Pharmaceutical and Biological Samples by Differential Pulse Polarography

机译:差分脉冲极谱法对药物和生物样品中抗化学治疗药物扎诺沙尔的电化学分析

获取原文
获取原文并翻译 | 示例
       

摘要

The electrochemical reduction of zanosar was investigated systematically by direct current polarography, cyclic voltammetry, and differential pulse polarography (DPP).AsimpleDPP technique was proposed for the direct quantitative determination of anticancer drug zanosar in pharmaceutical formulation and spiked human urine samples for the first time.The reduction potentialwas ?0.28V versus Ag/AgCl with a hanging mercury drop electrode in Britton-Robinson buffer as supporting electrolyte.The dependence of the intensities of currents and potentials on pH, concentration, scan rate, deposition time, and nature of the supporting electrolyte was investigated. The calibration curve was found to be linear with the following equation: y = 0.4041x + 0.012, with a correlation coefficient of 0.992 (R~2) over a concentration range from 1.0 × 10~(?7) M to 1.0 × 10~(?3) M. In the present investigation, the achieved limit of detection (LOD) and limit of quantization (LQD) were 7.42 × 10~(?8)M and 2.47 × 10~(?8) M; respectively. Excipients did not interfere with the determination of zanosar in pharmaceutical formulation and spiked urine samples. Precision and accuracy of the developed method were checked by recovery studies in pharmaceutical formulation and spiked human urine samples.
机译:通过直流极谱法,循环伏安法和微分脉冲极谱法(DPP)系统地研究了zanosar的电化学还原。首次提出了AsimpleDPP技术直接定量测定药物制剂和加标的人类尿液样品中的抗癌药物zanosar。相对于Ag / AgCl,还原电位为±0.28V,在Britton-Robinson缓冲液中使用悬挂的汞滴电极作为支撑电解质。电流和电位的强度对pH,浓度,扫描速率,沉积时间和支撑性质的依赖性研究了电解质。发现校准曲线与以下等式呈线性关系:y = 0.4041x + 0.012,在1.0×10〜(?7)M至1.0×10〜的浓度范围内,相关系数为0.992(R〜2)。 (?3)M。在本研究中,检测限(LOD)和定量限(LQD)为7.42×10〜(?8)M和2.47×10〜(?8)M。分别。赋形剂不干扰药物制剂和加标尿液样品中扎那沙的测定。通过药物制剂和加标的人类尿液样品中的回收率研究检查了开发方法的准确性和准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号